These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36069869)
1. Open-Source Automated Insulin Delivery in Type 1 Diabetes. Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI N Engl J Med; 2022 Sep; 387(10):869-881. PubMed ID: 36069869 [TBL] [Abstract][Full Text] [Related]
2. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial. Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI Diabetes Technol Ther; 2023 Apr; 25(4):250-259. PubMed ID: 36763345 [No Abstract] [Full Text] [Related]
3. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW; N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560 [TBL] [Abstract][Full Text] [Related]
4. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP; N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062 [TBL] [Abstract][Full Text] [Related]
5. Threshold-based insulin-pump interruption for reduction of hypoglycemia. Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR; N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889 [TBL] [Abstract][Full Text] [Related]
7. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. Wadwa RP; Reed ZW; Buckingham BA; DeBoer MD; Ekhlaspour L; Forlenza GP; Schoelwer M; Lum J; Kollman C; Beck RW; Breton MD; N Engl J Med; 2023 Mar; 388(11):991-1001. PubMed ID: 36920756 [TBL] [Abstract][Full Text] [Related]
8. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830 [TBL] [Abstract][Full Text] [Related]
9. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes. Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953 [TBL] [Abstract][Full Text] [Related]
10. AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol. Lee TTM; Collett C; Man MS; Hammond M; Shepstone L; Hartnell S; Gurnell E; Byrne C; Scott EM; Lindsay RS; Morris D; Brackenridge A; Dover AR; Reynolds RM; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Bocchino LE; Sibayan J; Kollman C; Wilinska ME; Hovorka R; Murphy HR; BMC Pregnancy Childbirth; 2022 Apr; 22(1):282. PubMed ID: 35382796 [TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes. Ware J; Allen JM; Boughton CK; Wilinska ME; Hartnell S; Thankamony A; de Beaufort C; Schierloh U; Fröhlich-Reiterer E; Mader JK; Kapellen TM; Rami-Merhar B; Tauschmann M; Nagl K; Hofer SE; Campbell FM; Yong J; Hood KK; Lawton J; Roze S; Sibayan J; Bocchino LE; Kollman C; Hovorka R; N Engl J Med; 2022 Jan; 386(3):209-219. PubMed ID: 35045227 [TBL] [Abstract][Full Text] [Related]
12. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010 [TBL] [Abstract][Full Text] [Related]
13. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995 [TBL] [Abstract][Full Text] [Related]
14. Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis. Petruzelkova L; Jiranova P; Soupal J; Kozak M; Plachy L; Neuman V; Pruhova S; Obermannova B; Kolouskova S; Sumnik Z Pediatr Diabetes; 2021 Jun; 22(4):594-604. PubMed ID: 33576551 [TBL] [Abstract][Full Text] [Related]
15. Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. Bally L; Thabit H; Hartnell S; Andereggen E; Ruan Y; Wilinska ME; Evans ML; Wertli MM; Coll AP; Stettler C; Hovorka R N Engl J Med; 2018 Aug; 379(6):547-556. PubMed ID: 29940126 [TBL] [Abstract][Full Text] [Related]
16. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663 [TBL] [Abstract][Full Text] [Related]
17. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
18. Home Use of an Artificial Beta Cell in Type 1 Diabetes. Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095 [TBL] [Abstract][Full Text] [Related]